Harvard Apparatus Regenerative Technology’s HART-Trachea Spotlighted In NBC-TV News Special On June 27
Published: Jun 30, 2014
HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology, Inc. (NASDAQ:HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, announces its HART-Trachea was spotlighted in a two-hour-long NBC-TV News Special on Friday, June 27.
Help employers find you! Check out all the jobs and post your resume.